[HTML][HTML] Cognitive impairment and decline in cognitively normal older adults with high amyloid-β: a meta-analysis

JE Baker, YY Lim, RH Pietrzak, J Hassenstab… - Alzheimer's & dementia …, 2017 - Elsevier
Introduction This meta-analysis aimed to characterize the nature and magnitude of amyloid
(Aβ)-related cognitive impairment and decline in cognitively normal (CN) older individuals …

Detectable neuropsychological differences in early preclinical Alzheimer's disease: A meta-analysis

S Duke Han, CP Nguyen, NH Stricker… - Neuropsychology review, 2017 - Springer
The development of methods for in vivo detection of cerebral beta amyloid retention and tau
accumulation have been increasingly useful in characterizing preclinical Alzheimer's …

AV-1451 PET imaging of tau pathology in preclinical Alzheimer disease: defining a summary measure

S Mishra, BA Gordon, Y Su, J Christensen… - Neuroimage, 2017 - Elsevier
Abstract Utilizing [18F]-AV-1451 tau positron emission tomography (PET) as an Alzheimer
disease (AD) biomarker will require identification of brain regions that are most important in …

Unsupervised high-frequency smartphone-based cognitive assessments are reliable, valid, and feasible in older adults at risk for Alzheimer's disease

J Nicosia, AJ Aschenbrenner, DA Balota… - Journal of the …, 2023 - cambridge.org
Objective: Smartphones have the potential for capturing subtle changes in cognition that
characterize preclinical Alzheimer's disease (AD) in older adults. The Ambulatory Research …

[HTML][HTML] Predictors of longitudinal cognitive ageing from age 70 to 82 including APOE e4 status, early-life and lifestyle factors: the Lothian Birth Cohort 1936

J Corley, F Conte, SE Harris, AM Taylor… - Molecular …, 2023 - nature.com
Discovering why some people's cognitive abilities decline more than others is a key
challenge for cognitive ageing research. The most effective strategy may be to address …

Association of β-amyloid level, clinical progression, and longitudinal cognitive change in normal older individuals

LM Van der Kall, T Truong, SC Burnham, V Doré… - Neurology, 2021 - AAN Enterprises
Objective To determine the effect of β-amyloid (Aβ) level on progression risk to mild
cognitive impairment (MCI) or dementia and longitudinal cognitive change in cognitively …

Neuropsychological measures that detect early impairment and decline in preclinical Alzheimer disease

SE Schindler, MS Jasielec, H Weng, JJ Hassenstab… - Neurobiology of …, 2017 - Elsevier
Identifying which neuropsychological measures detect early cognitive changes associated
with Alzheimer disease (AD), brain pathology would be helpful clinically for the diagnosis of …

NIA-AA staging of preclinical Alzheimer disease: discordance and concordance of CSF and imaging biomarkers

SJB Vos, BA Gordon, Y Su, PJ Visser, DM Holtzman… - Neurobiology of …, 2016 - Elsevier
Abstract The National Institute of Aging and Alzheimer's Association (NIA-AA) criteria for
Alzheimer disease (AD) treat neuroimaging and cerebrospinal fluid (CSF) markers of AD …

[HTML][HTML] Early cognitive and behavioral deficits in mouse models for tauopathy and Alzheimer's disease

C Samaey, A Schreurs, S Stroobants… - Frontiers in aging …, 2019 - frontiersin.org
Neurocognitive disorders, among which Alzheimer's disease (AD), have become one of the
major causes of death in developed countries. No effective disease-modifying therapy is …

Neuroimaging markers associated with maintenance of optimal memory performance in late-life

M Dekhtyar, KV Papp, R Buckley, HIL Jacobs… - Neuropsychologia, 2017 - Elsevier
Background Age-related memory decline has been well-documented; however, some
individuals reach their 8th− 10th decade while maintaining strong memory performance …